Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9M0R

Structure of neuropeptide FF receptor 1 complex with NPVF

Summary for 9M0R
Entry DOI10.2210/pdb9m0r/pdb
EMDB information63561
DescriptorGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2, neuropeptide VF, ... (6 entities in total)
Functional Keywordsgpcr, npffr1, npvf, npff, membrane protein/immune system, membrane protein-immune system complex
Biological sourceRattus norvegicus (Norway rat)
More
Total number of polymer chains6
Total formula weight156135.70
Authors
Pan, B.X.,Jiang, Y.,Li, X.Z. (deposition date: 2025-02-25, release date: 2025-07-23, Last modification date: 2025-09-03)
Primary citationLi, X.,Zhang, H.,Hu, W.,Wu, K.,Li, S.,Jin, S.,Yin, Y.,Yuan, Q.,Xu, H.E.,Pan, B.,Jiang, Y.
Structural basis of peptide recognition and modulation for neuropeptide FF receptors.
Cell Rep, 44:116160-116160, 2025
Cited by
PubMed Abstract: Neuropeptide FF receptors 1 and 2 (NPFFR1 and NPFFR2) are RF-amide peptide receptors that couple to G proteins and regulate pain, opioid tolerance, and metabolism. Despite their physiological significance, their ligand selectivity and activation mechanisms remain unclear. Using cryoelectron microscopy, we resolved four NPFFR1 and NPFFR2 structures bound to NPFF or NPVF, revealing conserved C-terminal RF-amide interactions within the orthosteric pocket and N-terminal variations driving subtype specificity. Structural and mutagenesis analyses identified ECL2 and the receptor N terminus as key determinants of NPVF-NPFFR1 and NPFF-NPFFR2 selectivity. Additionally, the structures elucidate the activation mechanism and uncover distinct G-coupling features between NPFFR subtypes. These findings provide molecular insights into peptide recognition and receptor activation within the RF-amide family, offering a structural framework for designing selective NPFFR modulators to treat pain, addiction, and metabolic disorders with enhanced specificity and reduced off-target effects.
PubMed: 40839429
DOI: 10.1016/j.celrep.2025.116160
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.47 Å)
Structure validation

242199

数据于2025-09-24公开中

PDB statisticsPDBj update infoContact PDBjnumon